囊型棘球蚴病并发症评分用于肝囊型棘球蚴病术前风险分层与手术规划的临床评价:回顾性推导与比较队列研究
该研究基于746例肝囊型棘球蚴病手术患者推导囊型棘球蚴病并发症评分(12个独立预测因子),并比较历史对照组(n=106)与评分指导组(n=110)。
要点
- 囊型棘球蚴病并发症评分由12个术后并发症独立预测因子加权构建。
- 评分指导术前评估与手术规划可降低术后并发症发生率及严重程度。
- 评分指导组26.4%患者术前管理调整,包括转诊、高年资医师参与和术前优化。
核心结论
- 囊型棘球蚴病并发症评分是肝囊型棘球蚴病术前风险分层的可行临床工具。
- 系统使用该评分与围术期决策改善和术后并发症负担降低相关。
研究设计与样本
- 回顾性队列研究,从2015年1月至2020年12月746例接受棘球蚴病切除术的患者中推导评分。
- 采用多变量logistic回归识别12个术后并发症独立预测因子并加权构建评分。
- 比较历史对照组(n=106,2018年1月至2020年12月,未行正式风险分层)与评分指导组(n=110,2021年1月至2023年12月)。
主要发现
- 评分指导组29例(26.4%)术前管理调整:转诊至更高级别中心11例、高年资外科医师参与14例、短程术前优化4例。
临床怎么用
- 可将囊型棘球蚴病并发症评分用于肝囊型棘球蚴病术前风险评估,辅助患者转诊、手术规划及围术期资源分配。
- 根据评分结果考虑术前管理调整,如转诊至更高级别中心、安排高年资外科医师或进行短程术前优化。
局限性
- 历史对照设计限制因果推断,观察到的改善可能反映机构经验演变。
- 需前瞻性、多中心外部验证确认评分的通用性和预测性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical management of hepatic cystic echinococcosis is frequently associated with substantial postoperative morbidity. The absence of a validated, disease-specific risk stratification tool hinders optimal patient referral, surgical planning, and perioperative resource allocation. This study evaluates the clinical utility of the Cystic Echinococcosis Complication Score for preoperative risk assessment and its association with postoperative outcomes. METHODS: The Cystic Echinococcosis Complication Score was derived from a retrospective cohort of 746 patients who underwent echinococcectomy between January 2015 and December 2020. Multivariable logistic regression identified 12 independent predictors of postoperative complications, which were weighted to construct the Cystic Echinococcosis Complication Score. To evaluate its clinical impact, we conducted a retrospective comparative analysis of 2 sequential cohorts: a historical control group managed without formal risk stratification (n = 106, January 2018-December 2020) and a Cystic Echinococcosis Complication Score-guided group where preoperative assessment and surgical planning were systematically informed by the score (n = 110, January 2021-December 2023). Primary outcomes included the incidence and severity of postoperative complications (Clavien-Dindo classification) and preoperative tactical modifications. RESULTS: Implementation of Cystic Echinococcosis Complication Score-guided risk stratification was associated with a significant reduction in overall postoperative complications (12.7% vs 31.1%; χ2 = 10.741; P = .001) and a decrease in clinically significant complications (Clavien-Dindo III-V: 0.9% vs 5.7%; P = .031). Preoperative management was modified in 29 patients (26.4%) in the Cystic Echinococcosis Complication Score cohort, including referral to higher-level centers (n = 11), involvement of senior surgeons (n = 14), and short-course preoperative optimization (n = 4). Median hospital stay was shorter in the Cystic Echinococcosis Complication Score group (6.2 vs 7.5 days; P = .0002). CONCLUSION: The Cystic Echinococcosis Complication Score is a feasible, clinically applicable tool for preoperative risk stratification in hepatic cystic echinococcosis. Its systematic use was associated with improved perioperative decision-making and a lower burden of postoperative complications. Given the historical control design, causal inference is limited, and observed improvements may also reflect evolving institutional expertise. Prospective, multicenter external validation is warranted to confirm the score's generalizability and predictive performance.
引用
- Sapaev DS, Yakubov FR, Khodjiev DS, et al. Clinical evaluation of the Cystic Echinococcosis Complication Score for preoperative risk stratification and surgical planning in hepatic cystic echinococcosis: A retrospective derivation and comparative cohort study. Surgery. 2026. PMID: 42685635. doi:10.1016/j.surg.2026.110491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。